Saelee RK - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Real-World Experience with ¹⁷⁷Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval.

Moradi Tuchayi A, Yadav S, Jiang F, Kim ST, Saelee RK, Morley A, Juarez R, Lawhn-Heath C, Wang Y, de Kouchkovsky I, Hope TA. Moradi Tuchayi A, et al. Among authors: saelee rk. J Nucl Med. 2024 May 1;65(5):735-739. doi: 10.2967/jnumed.123.266842. J Nucl Med. 2024. PMID: 38485274 Free article.

Assessing Response to PSMA Radiopharmaceutical Therapies with Single SPECT Imaging at 24 Hours After Injection.

Yadav S, Jiang F, Kurkowska S, Saelee R, Morley A, Feng F, Aggarwal R, Lawhn-Heath C, Uribe C, Hope TA. Yadav S, et al. J Nucl Med. 2024 Jul 1;65(7):1064-1069. doi: 10.2967/jnumed.123.267208. J Nucl Med. 2024. PMID: 38724282

Comparison of ¹⁸F-DCFPyL and ⁶⁸Ga-PSMA-11 for ¹⁷⁷Lu-PSMA-617 therapy patient selection.

Yadav S, Kim ST, Tuchayi AM, Jiang F, Morley A, Saelee R, Wang Y, Juarez R, Lawnh-Heath C, Koshkin VS, Hope TA. Yadav S, et al. Front Oncol. 2024 Jun 27;14:1382582. doi: 10.3389/fonc.2024.1382582. eCollection 2024. Front Oncol. 2024. PMID: 38993644 Free PMC article.

Impact of Posttreatment SPECT/CT on Patient Management During ¹⁷⁷Lu-PSMA-617 Radiopharmaceutical Therapy.

Yadav S, Lowery B, Tuchayi AM, Jiang F, Saelee R, Aggarwal RR, Juarez R, Flavell RR, Hope TA. Yadav S, et al. J Nucl Med. 2024 Sep 3;65(9):1395-1401. doi: 10.2967/jnumed.124.267955. J Nucl Med. 2024. PMID: 39117452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters